The Global Sleep Apnea Devices Market size is expected to be worth around USD 17.4 Billion by 2033, from USD 8.7 Billion in 2023, growing at a CAGR of 7.2% during the forecast period from 2024 to 2033.
The Sleep Apnea Device Market is evolving in 2025 with advanced oral appliances and custom 3D-fitting workflows. Dental labs now employ intraoral scanners and CAD/CAM milling to produce tailor-made mandibular advancement devices (MADs) using lightweight, hypoallergenic materials. Digital workflows allow dentists to scan patient anatomy, generate dynamic bite simulation, and print prototypes for at-home test fitting. Final appliances are refined in-office in a single visit.
These personalized devices offer comfortable alternatives to CPAP, with patient satisfaction rates climbing above 80%. Sleep apnea specialists are referring more suitable mild-to-moderate OSA patients to oral appliance therapy based on efficacy data. As 3D printing and dental integration mature, custom OSA devices are becoming mainstream—offering effective, patient-centric solutions that complement or substitute PAP therapy.
Click here for more information:
https://market.us/report/sleep-apnea-device-market/Key Takeaways
In 2023, the Sleep Apnea Devices Market was valued at USD 8.7 Billion.
This market is estimated to reach USD 17.4 Billion by 2033.
The sleep apnea devices market is projected to grow at a CAGR of 7.2% from 2024-2033.
In 2019, 170 million individuals in the U.S. were diagnosed with obstructive sleep apnea.
Almost 40% of the obese population across the world has sleep apnea.
Among those with sleep apnea, approximately 70% are obese.
The average cost of sleep apnea devices like CPAP and PSG in the U.S. is between USD 600 to USD 800.
Therapeutic devices dominate the global sleep apnea devices market with a revenue share of 76.8%.
North America holds a major revenue share in the global sleep apnea devices market at 47.6%.
According to the American Academy of Sleep Medicine, 2-5% of women and 3-7% of men globally have sleep apnea.
The diagnostic devices segment in the sleep apnea devices market includes respiratory polygraphs, polysomnography (PSG) devices, actigraphs, and pulse oximeters.
Key Market Segments
By Device Type
Therapeutic Devices
Nasal Devices
Oral Devices
Positive Airway Pressure (PAP) Devices
Chin Straps
Diagnostic Devices
Respiratory Polygraphs
Polysomnography (PSG) Device
Actigraphs
Pulse Oximeters
By End-User
Sleep Laboratories & Hospitals
Home Care Settings
Emerging Trends
CAD/CAM workflows for custom-fitted mandibular advancement devices.
Intraoral scanning combined with 3D-printed prototypes for trial fitting.
Hypoallergenic, lightweight materials improving patient comfort.
Broad referral adoption of oral devices for mild-to-moderate sleep apnea.
Use Cases
A patient receives a trial 3D-printed MAD and tests comfort before final milling.
Dentist adjusts final device in one visit after patient confirms initial fit.
Mild-OSA patient opts for oral therapy after showing intolerance to CPAP.
Sleep clinicians monitor efficacy data and refer patients to in-office printing providers.
Locked
